Agreement between nonculprit stenosis follow-up iFR and FFR after STEMI (iSTEMI substudy).


Journal

BMC research notes
ISSN: 1756-0500
Titre abrégé: BMC Res Notes
Pays: England
ID NLM: 101462768

Informations de publication

Date de publication:
01 Sep 2020
Historique:
received: 25 06 2020
accepted: 21 08 2020
entrez: 3 9 2020
pubmed: 3 9 2020
medline: 15 5 2021
Statut: epublish

Résumé

To evaluate agreement between instantaneous wave free ratio (iFR) and fractional flow reserve (FFR) for the functional assessment of nonculprit coronary stenoses at staged follow-up after ST-segment elevation myocardial infarction (STEMI). We measured iFR and FFR at staged follow-up in 112 STEMI patients with 146 nonculprit stenoses. Median interval between STEMI and follow-up was 16 (interquartile range 5-32) days. Agreement between iFR and FFR was 77% < 5 days after STEMI and 86% after ≥ 5 days (p = 0.19). Among cases with disagreement, the proportion of cases with hemodynamically significant iFR and non-significant FFR were different when assessed < 5 days (5 in 8, 63%) versus ≥ 5 days (3 in 15, 20%) after STEMI (p = 0.04). Overall classification agreement between iFR and FFR was comparable to that observed in stable patients. Time interval between STEMI and follow-up evaluation may impact agreement between iFR and FFR.

Identifiants

pubmed: 32873327
doi: 10.1186/s13104-020-05252-6
pii: 10.1186/s13104-020-05252-6
pmc: PMC7466494
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

410

Subventions

Organisme : The Netherlands Organisation for Health Research and Development
ID : 90714544

Références

JAMA Cardiol. 2019 Aug 1;4(8):736-744
pubmed: 31268466
EuroIntervention. 2013 May 20;9(1):91-101
pubmed: 22917666
Open Heart. 2016 Jun 24;3(1):e000427
pubmed: 27403331
Coron Artery Dis. 2020 Aug;31(5):411-416
pubmed: 32168054
N Engl J Med. 2017 May 11;376(19):1824-1834
pubmed: 28317458
Am Heart J. 2017 Nov;193:63-69
pubmed: 29129256
JACC Cardiovasc Interv. 2020 May 25;13(10):1145-1154
pubmed: 32438985
JACC Cardiovasc Interv. 2016 Mar 28;9(6):602-13
pubmed: 27013161
N Engl J Med. 2017 May 11;376(19):1813-1823
pubmed: 28317438
JACC Cardiovasc Interv. 2017 Dec 26;10(24):2528-2535
pubmed: 29198461

Auteurs

Troels Thim (T)

Department of Cardiology, Aarhus University Hospital, Palle Juul-Jensens Boulevard 99, 8200, Aarhus N, Denmark. troels.thim@clin.au.dk.

Matthias Götberg (M)

Department of Cardiology, Skåne University Hospital, Malmö, Sweden.

Ole Fröbert (O)

Department of Cardiology, Örebro University, Örebro, Sweden.

Robin Nijveldt (R)

Department of Cardiology, Radboud University Medical Center, Nijmegen, The Netherlands.

Niels van Royen (N)

Department of Cardiology, Radboud University Medical Center, Nijmegen, The Netherlands.

Sergio Bravo Baptista (SB)

Cardiology Department, Hospital Prof. Doutor Fernando Fonseca, Amadora, Portugal.

Sasha Koul (S)

Department of Cardiology, Skåne University Hospital, Malmö, Sweden.

Thomas Kellerth (T)

Department of Cardiology, Örebro University, Örebro, Sweden.

Hans Erik Bøtker (HE)

Department of Cardiology, Aarhus University Hospital, Palle Juul-Jensens Boulevard 99, 8200, Aarhus N, Denmark.

Christian Juhl Terkelsen (CJ)

Department of Cardiology, Aarhus University Hospital, Palle Juul-Jensens Boulevard 99, 8200, Aarhus N, Denmark.

Evald Høj Christiansen (EH)

Department of Cardiology, Aarhus University Hospital, Palle Juul-Jensens Boulevard 99, 8200, Aarhus N, Denmark.

Lars Jakobsen (L)

Department of Cardiology, Aarhus University Hospital, Palle Juul-Jensens Boulevard 99, 8200, Aarhus N, Denmark.

Steen Dalby Kristensen (SD)

Department of Cardiology, Aarhus University Hospital, Palle Juul-Jensens Boulevard 99, 8200, Aarhus N, Denmark.

Michael Maeng (M)

Department of Cardiology, Aarhus University Hospital, Palle Juul-Jensens Boulevard 99, 8200, Aarhus N, Denmark.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH